Phio Pharmaceuticals

PHIO

Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Phio Pharmaceuticals has been a target of short sellers for a while. The current short interest of 1.91% is roughly at the average of the last 12 months (3.81%).